| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |